BIOTECHNOLOGY VALUE FUND L P 3 SEC Filings

Filed On	Filing
05 Oct 2026	Form 3: Bvf Partners L P/IL, 10% owner and 9 others · Foghorn Therapeutics Inc. Holds 4,494,462 shares of Common Stock, $0.0001 par value per share
27 Feb 2026	Form 3: Bvf Partners L P/IL, Director and 9 others · Immunic, Inc. Holds 4,135,956 shares of Common Stock, $0.0001 par value
01 Aug 2024	Form 3: Bvf Partners L P/IL, 10% owner and 9 others · 4D Molecular Therapeutics Inc Holds 3,892,237 shares of Common Stock, $0.0001 par value
26 Jan 2024	Form 3: Bvf Partners L P/IL, 10% owner and 9 others · Allakos Inc. Holds 8,679,726 shares of Common Stock, $0.001 par value
13 Nov 2023	Form 3: Bvf Partners L P/IL, 10% owner and 9 others · enGene Therapeutics Inc. Holds 1,204,412 shares of Class A Common Shares
06 Nov 2023	Form 3: Bvf Partners L P/IL, 10% owner and 9 others · POINT Biopharma Global Inc. Holds 8,974,245 shares of Common Stock, $0.0001 par value
22 May 2023	Form 3: Bvf Partners L P/IL, 10% owner and 9 others · Palvella Therapeutics Inc Holds 11,007,420 shares of Common Stock, $0.001 par value
13 Feb 2023	Form 3: Bvf Partners L P/IL, 10% owner and 9 others · Structure Therapeutics Inc. Holds 4,018,253 shares of Ordinary Shares, $0.0001 par value per share
22 Dec 2022	Form 3: Bvf Partners L P/IL, 10% owner and 9 others · Third Harmonic Bio, Inc. Holds 2,216,003 shares of Common Stock
21 Jul 2022	Form 3: Bvf Partners L P/IL, 10% owner and 9 others · ESSA Pharma Inc. Holds 4,712,590 shares of Common Stock
27 Jun 2022	Form 3: Bvf Partners L P/IL, 10% owner and 9 others · 4D Molecular Therapeutics Inc Holds 2,132,411 shares of Common Stock
15 Apr 2022	Form 3: Bvf Partners L P/IL, Director and 9 others · MoonLake Immunotherapeutics Holds 11,265,678 shares of Class A Ordinary Shares, $0.0001 par value
07 Feb 2022	Form 3: Bvf Partners L P/IL, 10% owner and 9 others · Verastem Inc Holds 10,753,294 shares of Common Stock
31 Jan 2022	Form 3: Bvf Partners L P/IL, 10% owner and 9 others · Eledon Pharmaceuticals Inc Holds 1,274,973 shares of Common Stock, $0.001 par value
10 Jan 2022	Form 3: Bvf Partners L P/IL, 10% owner and 9 others · Cullinan Therapeutics, Inc. Holds 2,790,018 shares of Common Stock
08 Nov 2021	Form 3: Bvf Partners L P/IL, 10% owner and 9 others · Repare Therapeutics Inc. Holds 2,548,764 shares of Common Stock
27 Apr 2021	Form 3: Bvf Partners L P/IL, Director and 9 others · Rain Oncology Inc.
08 Mar 2021	Form 3: Bvf Partners L P/IL, 10% owner and 9 others · FIVE PRIME THERAPEUTICS, INC. Holds 3,372,098 shares of Common Stock, $0.001 par value per share
28 Dec 2020	Form 3: Bvf Partners L P/IL, 10% owner and 9 others · CytomX Therapeutics, Inc. Holds 2,945,743 shares of Common Stock, $0.00001 par value per share
04 Dec 2020	Form 3: Bvf Partners L P/IL, 10% owner and 9 others · Cytokinetics, Incorporated Holds 4,050,545 shares of Common Stock, $0.001 par value

Comments